Blanket Purchase Agreement V797D60637-36C25024A0005

Award Date 1/1/24
Last Date to Order 12/31/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 awarded a Blanket Purchase Agreement (BPA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, to provide an immunohematology analyzer system, associated training, support, and reagents. The BPA has a potential value of $249,000 and a period of performance through December 2028. This contract supports the VA's medical equipment and diagnostic...
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Ortho-Clinical Diagnostics Inc. for blood bank analyzer products and services. The single award BPA was established against the Critical Analyzers, Laboratory GSA schedule and carries a potential value of $185,248.65. No set-aside was used in the award. The BPA aims to procure blood bank analyzer equipment to support the VA's healthcare...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 10, a component of the U.S. Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. to provide a blood bank analyzer system, associated reagents and consumables, as well as training and support services. The contract has a total ceiling value of $431,202.75 and a period of performance extending through September 2029. Ortho-Clinical Diagnostics, a for-profit medical equipment manufacturer,...
This is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the U.S. Department of Veterans Affairs (VA), to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract, valued at $734,484.35, is for the procurement of blood bank analyzers, reagents, and consumables in support of federal healthcare programs. It is a single-award IDV under the Critical Analyzers, Laboratory (FSS-66-III) GSA...
The Department of Veterans Affairs, Veterans Health Administration awarded a $115,160 firm fixed price blanket purchase agreement call contract to Ortho-Clinical Diagnostics, Inc. to provide ORTHOVISION CPT products and services in support of the VA's Veterans Integrated Service Network 10 programs. The one-year contract against Ortho-Clinical Diagnostics' existing GSA Schedule 66-III vehicle for critical medical devices will deliver their critical analyzers and laboratory equipment from...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs' (VA) Veterans Integrated Service Network (VISN) 19 to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract, with a total ceiling value of $412,145.05, provides a blood bank gel analyzer and associated cost-per-test services to VISN 19 facilities through September 2026. The BPA was issued under the GSA's Critical Analyzers, Laboratory Federal Supply Schedule...
The Department of Veterans Affairs Veterans Health Administration awarded a Blanket Purchase Agreement (BPA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, to provide automated blood bank instrumentation and associated services to support the agency's Veterans Integrated Service Network 10 covering central New Jersey. The BPA has a ceiling value of $370,497.30 and a period of performance through September 30, 2025. Under this IDV, Ortho-Clinical Diagnostics...
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA) awarded a single-award Blanket Purchase Agreement (BPA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, to provide wide automated blood bank cost-per-test (CPT) services. The $1,595,054.40 BPA, originally awarded in May 2018, supports the VA's Veterans Integrated Service Networks (VISNs) 21 and 22 by facilitating on-demand access to critical blood bank testing and laboratory...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, under the Critical Analyzers, Laboratory (FSS-66-III) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract, valued at a total ceiling of $1,116,854.35, is for the provision of blood bank analyzers, reagents, and quality control products to support VA healthcare programs, specifically at the...
This Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs' (VA) Veterans Integrated Service Network (VISN) 23 to Ortho-Clinical Diagnostics, Inc. is for the provision of Ortho Immunochemistry products and services. Ortho-Clinical Diagnostics is a for-profit medical equipment manufacturer that has previously provided a range of diagnostic solutions, including critical analyzers, reagents, and blood bank services, to various federal agencies under...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a blanket purchase agreement to Ortho-Clinical Diagnostics Inc. for an immunohematology analyzer system under the company's existing GSA Schedule 66-III contract. The five-year BPA, with a potential value of $249,000, provides the VA network with an immunohematology analyzer, associated reagents, training and support from the vendor. A firm-fixed price call was also placed against this BPA for $37,677.09 to acquire the analyzer and support for the Raritan, New Jersey site through December 2024.

The original special notice solicitation aimed to justify awarding a sole source, five-year BPA with four option years to Ortho-Clinical Diagnostics Inc. as the immunohematology system must be compatible with the VA's existing manual equipment and methodology to ensure continued standardization, employee safety, and quality care for veterans. Responses to the notice were due by November 3, 2023 to show how competition would benefit the government, as the agency determined only the incumbent vendor could meet its compatibility and support requirements for the blood bank analysis equipment. The BPA and associated call orders aim to continue reliable immunohematology testing to serve veterans through this vendor-provided integrated solution.

Generated 1/4/24, 6:28 PM